Education
About Us
Working with TipRanks
Follow Us
Spectral Medical (TSE:EDT)
TSX:EDT
EDT Stock Chart & Stats
C$1.27
-C$0.01(-1.75%)
At close: 4:00 PM EST
C$1.27
-C$0.01(-1.75%)
Day’s Range― - ―
52-Week RangeC$0.46 - C$1.84
Previous CloseN/A
Volume37.78K
Average Volume (3M)78.93K
Market Cap
C$371.54M
Enterprise ValueC$433.79M
Total Cash (Recent Filing)C$5.89M
Total Debt (Recent Filing)C$20.96M
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Mar 26, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding292,549,600
10 Day Avg. Volume98,063
30 Day Avg. Volume78,934
Financial Highlights & Ratios
PEG Ratio3.66
Price to Book (P/B)-5.10
Price to Sales (P/S)61.48
P/FCF Ratio-15.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Spectral Medical News
EDT FAQ
What was Spectral Medical’s price range in the past 12 months?
Spectral Medical lowest stock price was C$0.46 and its highest was C$1.84 in the past 12 months.
What is Spectral Medical’s market cap?
Spectral Medical’s market cap is C$371.54M.
When is Spectral Medical’s upcoming earnings report date?
Spectral Medical’s upcoming earnings report date is Mar 26, 2026 which is in 87 days.
How were Spectral Medical’s earnings last quarter?
Spectral Medical released its earnings results on Nov 07, 2025. The company reported -C$0.11 earnings per share for the quarter, missing the consensus estimate of -C$0.01 by -C$0.1.
Is Spectral Medical overvalued?
According to Wall Street analysts Spectral Medical’s price is currently Overvalued.
Does Spectral Medical pay dividends?
Spectral Medical pays a Notavailable dividend of C$0.12 which represents an annual dividend yield of N/A. See more information on Spectral Medical dividends here
What is Spectral Medical’s EPS estimate?
Spectral Medical’s EPS estimate is -0.01.
How many shares outstanding does Spectral Medical have?
Spectral Medical has 292,549,600 shares outstanding.
What happened to Spectral Medical’s price movement after its last earnings report?
Spectral Medical reported an EPS of -C$0.11 in its last earnings report, missing expectations of -C$0.01. Following the earnings report the stock price went down -0.694%.
Which hedge fund is a major shareholder of Spectral Medical?
Currently, no hedge funds are holding shares in TSE:EDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Spectral Medical
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Technical Analysis
Cipher Pharmaceuticals
―
BioMark Diagnostics
―
kneat.com
―
Profound Medical
―
Sona Nanotech Inc
―
Options Prices
Currently, No data available
---